WisdomTree BioRevolution Fund (BATS:WDNA – Get Free Report)’s share price dropped 0.9% on Friday . The stock traded as low as $12.87 and last traded at $13.14. Approximately 465 shares changed hands during mid-day trading, a decline of 48% from the average daily volume of 890 shares. The stock had previously closed at $13.26.
WisdomTree BioRevolution Fund Stock Down 0.9%
The company has a market cap of $1.97 million, a P/E ratio of 12.58 and a beta of 1.01. The firm’s 50 day moving average is $12.57 and its two-hundred day moving average is $13.82.
Institutional Trading of WisdomTree BioRevolution Fund
A hedge fund recently raised its stake in WisdomTree BioRevolution Fund stock. Jane Street Group LLC increased its holdings in WisdomTree BioRevolution Fund (BATS:WDNA – Free Report) by 21.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 15,908 shares of the company’s stock after purchasing an additional 2,774 shares during the quarter. Jane Street Group LLC owned approximately 10.61% of WisdomTree BioRevolution Fund worth $229,000 at the end of the most recent reporting period.
About WisdomTree BioRevolution Fund
The WisdomTree BioRevolution Fund (WDNA) is an exchange-traded fund that is based on the WisdomTree BioRevolution index. The fund tracks a modified equally-weighted index of companies in developed markets that focus on the advancements in genetics and biotechnology. WDNA was launched on Jun 3, 2021 and is managed by WisdomTree.
Recommended Stories
- Five stocks we like better than WisdomTree BioRevolution Fund
- 3 Best Fintech Stocks for a Portfolio Boost
- IBM Up 10 Days in a Row: What’s Driving the Winning Streak?
- Pros And Cons Of Monthly Dividend Stocks
- Upstart Stock’s Bull Case Just Got a Lot Stronger
- Manufacturing Stocks Investing
- Higher Gulf Oil Output Puts These Energy Names in Play
Receive News & Ratings for WisdomTree BioRevolution Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WisdomTree BioRevolution Fund and related companies with MarketBeat.com's FREE daily email newsletter.